EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target

Teresa Santos-Mendoza iD

Viruses · 2023

DOI: 10.3390/v15041000 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2023. Verfasst von Teresa Santos-Mendoza. Beteiligte Einrichtung: Laboratory of Transcriptomics and Molecular Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Me…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Enfermedades Respiratorias.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic caused by the SARS-CoV-2 virus is still a global health concern. Several spike (S) protein-based vaccines have been developed that efficiently protect the human population against severe forms of COVID-19. However, some SARS-CoV-2 variants of concern (VOCs) have emerged that evade the protective effect of vaccine-induced antibodies. Therefore, efficient and specific antiviral treatments to control COVID-19 are indispensable. To date, two drugs have been approved for mild COVID-19 treatment; nevertheless, more drugs, preferably broad-spectrum and ready-to-use therapeutic agents for new pandemics, are needed. Here, I discuss the PDZ-dependent protein-protein interactions of the viral E protein with host proteins as attractive alternatives for the development of antivirals against coronavirus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansPandemicsCOVID-19 Drug TreatmentAntiviral AgentsAntibodies, ViralSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

PDZ-dependent interactionsantiviralscoronavirus E protein

Substanzen

Antiviral AgentsAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Laboratory of Transcriptomics and Molecular Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.

ORCID-Profile: Teresa Santos-Mendoza

Förderung

  • Instituto Nacional de Enfermedades Respiratorias

Zitieren

APA

Santos-Mendoza, T. (2023). The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target. Viruses. https://doi.org/10.3390/v15041000

Vancouver

Santos-Mendoza T. The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target. Viruses. 2023. doi:10.3390/v15041000

BibTeX
@article{SantosMendoza2023,
  author = {Santos-Mendoza, Teresa},
  title = {The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15041000}
}
Kostenlos starten →